Description
Meropenem is a β-lactam antibiotic that belongs to the family of carbapenems, active against all bacteria, with the most significant antibacterial activity against gram-negative species. Meropenem is somewhat resistant to degradation by β-lactamases and is used to treat bacterial meningitis, skin infections, and febrile neutropenia. This compound inhibits bacterial cell wall synthesis by binding penicillin-binding proteins 2 and 3 (PBP2/3), preventing formation of peptidoglycan.
References
Mallick M, Odedra D, Vidyarthi AS, et al. Meropenem: a potent drug against superbug as unveiled through bioinformatics approaches. Int J Bioinform Res Appl. 2013;9(2):109-20. PMID: 23467058.
Pernot L, Frénois F, Rybkine T, et al. Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem. J Mol Biol. 2001 Jul 20;310(4):859-74. PMID: 11453693.
Sumita Y, Fukasawa M. Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3. J Antimicrob Chemother. 1995 Jul;36(1):53-64. PMID: 8537284.
ABOUT LKT LABS
LKT Laboratories is a biochemical supply company focused on the synthesis, purification, and isolation of small molecules for research applications. Its range of products exhibit known biological activities that have found uses in a wide array of research fields, especially cancer and neuroscience. These products include protein kinase inhibitors, ion channel modulators, and activators. LKT serves the global research community by supplying the highest purity products for use in cell culture models, animal studies, or as reference materials or analytical standards.